Referenced via search only ("Case Study - Patient Input in Trial Recruitment") — same as Smart Patients entry above (duplicate title indexed differently
Unnamed referenced via search only ("Case Study - Patient Input in Trial Recruitment") — same as Smart Patients entry above (duplicate title indexed differently — the customer is anonymised in the vendor’s own case study, not withheld by us.
Norstella is a holding company merging several pharma-intelligence brands — Citeline (trial intelligence), Evaluate (forecasting), MMIT (payer/formulary data) and Panalgo (real-world analytics) — into one data asset.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Norstella on its own site, referenced in Norstella’s own case-study library without a standalone URL.
Related use cases
- 01MMIT used NorstellaLinQ to merge unstructured EMR data with structured data to detect disease screening patterns and drive commercialization strategy
- 02MMIT used NorstellaLinQ real-world data to narrow a target patient population and improve physician targeting
- 03MMIT used NorstellaLinQ to give a clearer real-time picture of high-risk patients and the physicians treating them
- 04Panalgo linked unstructured EMR data (via NorstellaLinQ) with closed claims data for an HEOR study on knee arthroplasty, delivering years of longitudinal data in 8 weeks
- 05"NorstellaLinQ: Better together — Getting the full patient picture" use case
- 06CRO used Citeline to validate site/investigator hypotheses for a Phase III oncology "trial rescue," uncovering protocol constraints and competitive-intensity insights